BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chong PY, Shotwell JB, Miller J, Price DJ, Maynard A, Voitenleitner C, Mathis A, Williams S, Pouliot JJ, Creech K, Wang F, Fang J, Zhang H, Tai VW, Turner E, Kahler KM, Crosby R, Peat AJ. Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. J Med Chem 2019;62:3254-67. [PMID: 30763090 DOI: 10.1021/acs.jmedchem.8b01719] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang S, Ren Y, Wang Z, Jiang X, Xu S, Zhang X, Zhao S, Zalloum WA, Liu X, Zhan P. The current progress in the use of boron as a platform for novel antiviral drug design. Expert Opinion on Drug Discovery 2022. [DOI: 10.1080/17460441.2023.2153829] [Reference Citation Analysis]
2 Ramaswamy K, Rashid M, Ramasamy S, Jayavelu T, Venkataraman S. Revisiting Viral RNA-Dependent RNA Polymerases: Insights from Recent Structural Studies. Viruses 2022;14:2200. [PMID: 36298755 DOI: 10.3390/v14102200] [Reference Citation Analysis]
3 You T, Li J. Ni(cod)(duroquinone)-Catalyzed C-N Cross-Coupling for the Synthesis of N,N-Diarylsulfonamides. Org Lett 2022. [PMID: 36067509 DOI: 10.1021/acs.orglett.2c02670] [Reference Citation Analysis]
4 Zhou Z, Zhang J, Zhou E, Ren C, Wang J, Wang Y. Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective. Eur J Med Chem 2022;240:114595. [PMID: 35868125 DOI: 10.1016/j.ejmech.2022.114595] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu S, Song S, Sun L, Gao P, Gao S, Ma Y, Kang D, Cheng Y, Zhang X, Cherukupalli S, De Clercq E, Pannecouque C, Liu X, Zhan P. Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 2022;53:116531. [PMID: 34890994 DOI: 10.1016/j.bmc.2021.116531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Steketee PC, Giordani F, Vincent IM, Crouch K, Achcar F, Dickens NJ, Morrison LJ, MacLeod A, Barrett MP. Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole. PLoS Negl Trop Dis 2021;15:e0009939. [PMID: 34752454 DOI: 10.1371/journal.pntd.0009939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Song S, Gao P, Sun L, Kang D, Kongsted J, Poongavanam V, Zhan P, Liu X. Recent developments in the medicinal chemistry of single boron atom-containing compounds. Acta Pharm Sin B 2021;11:3035-59. [PMID: 34729302 DOI: 10.1016/j.apsb.2021.01.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 32.0] [Reference Citation Analysis]
8 Martinez MA, Franco S. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection. Adv Exp Med Biol 2021;1322:139-57. [PMID: 34258740 DOI: 10.1007/978-981-16-0267-2_6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rout L, Punniyamurthy T. Recent advances in transition-metal-mediated Csp2-B and Csp2-P cross-coupling reactions. Coordination Chemistry Reviews 2021;431:213675. [DOI: 10.1016/j.ccr.2020.213675] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 23.0] [Reference Citation Analysis]
10 Bhutani P, Joshi G, Raja N, Bachhav N, Rajanna PK, Bhutani H, Paul AT, Kumar R. U.S. FDA Approved Drugs from 2015-June 2020: A Perspective. J Med Chem 2021;64:2339-81. [PMID: 33617716 DOI: 10.1021/acs.jmedchem.0c01786] [Cited by in Crossref: 106] [Cited by in F6Publishing: 120] [Article Influence: 106.0] [Reference Citation Analysis]
11 Feng D, Wei F, Sun Y, Sharma PP, Zhang T, Lin H, Rathi B, De Clercq E, Pannecouque C, Kang D, Zhan P, Liu X. Boronic acid-containing diarylpyrimidine derivatives as novel HIV-1 NNRTIs: Design, synthesis and biological evaluation. Chinese Chemical Letters 2021. [DOI: 10.1016/j.cclet.2021.02.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Martinez MA, Franco S. Therapy Implications of Hepatitis C Virus Genetic Diversity. Viruses 2020;13:E41. [PMID: 33383891 DOI: 10.3390/v13010041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
13 Lamaa D, Hauguel C, Lin HP, Messe E, Gandon V, Alami M, Hamze A. Sequential One-Pot Synthesis of 3-Arylbenzofurans from N-Tosylhydrazones and Bromophenol Derivatives. J Org Chem 2020;85:13664-73. [PMID: 33091298 DOI: 10.1021/acs.joc.0c01835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Silva MP, Saraiva L, Pinto M, Sousa ME. Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications. Molecules 2020;25:E4323. [PMID: 32967170 DOI: 10.3390/molecules25184323] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
15 Plescia J, Moitessier N. Design and discovery of boronic acid drugs. European Journal of Medicinal Chemistry 2020;195:112270. [DOI: 10.1016/j.ejmech.2020.112270] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 34.5] [Reference Citation Analysis]
16 Li X, Wu S, Dong G, Chen S, Ma Z, Liu D, Sheng C. Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer. ACS Med Chem Lett 2020;11:439-44. [PMID: 32292547 DOI: 10.1021/acsmedchemlett.9b00513] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
17 Xiao D, Dai X, Liu H, He S, Shi ZC, Ludmerer SW, Li F, Nargund R, Palani A. Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B. Bioorg Med Chem Lett 2020;30:127004. [PMID: 32061500 DOI: 10.1016/j.bmcl.2020.127004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Becica J, Hruszkewycz DP, Steves JE, Elward JM, Leitch DC, Dobereiner GE. High-Throughput Discovery and Evaluation of a General Catalytic Method for N-Arylation of Weakly Nucleophilic Sulfonamides. Org Lett 2019;21:8981-6. [PMID: 31651171 DOI: 10.1021/acs.orglett.9b03380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
19 Xing QQ, Liu LW, Zhao X, Lu Y, Dong YM, Liang ZQ. Serum proteomics analysis based on label-free revealed the protective effect of Chinese herbal formula Gu-Ben-Fang-Xiao. Biomed Pharmacother 2019;119:109390. [PMID: 31520916 DOI: 10.1016/j.biopha.2019.109390] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
20 Zhang H, Xie F, Cheng M, Peng F. Novel Meta-iodobenzylguanidine-Based Copper Thiosemicarbazide-1-guanidinomethylbenzyl Anticancer Compounds Targeting Norepinephrine Transporter in Neuroblastoma. J Med Chem 2019;62:6985-91. [DOI: 10.1021/acs.jmedchem.9b00386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
21 Fernandes GFS, Denny WA, Dos Santos JL. Boron in drug design: Recent advances in the development of new therapeutic agents. Eur J Med Chem 2019;179:791-804. [PMID: 31288128 DOI: 10.1016/j.ejmech.2019.06.092] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 33.0] [Reference Citation Analysis]
22 Wu G, Zhao T, Kang D, Zhang J, Song Y, Namasivayam V, Kongsted J, Pannecouque C, De Clercq E, Poongavanam V, Liu X, Zhan P. Overview of Recent Strategic Advances in Medicinal Chemistry. J Med Chem 2019;62:9375-414. [PMID: 31050421 DOI: 10.1021/acs.jmedchem.9b00359] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 22.3] [Reference Citation Analysis]
23 Yamada, Masuda, Park, Tachikawa, Ito, Ichikawa, Yoshimura, Takagi, Sawama, Ohya, Sajiki. Development of Titanium Dioxide-Supported Pd Catalysts for Ligand-Free Suzuki–Miyaura Coupling of Aryl Chlorides. Catalysts 2019;9:461. [DOI: 10.3390/catal9050461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
24 Zhan P, Kang D, Liu X. Resurrecting the Condemned: Identification of N -Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability. J Med Chem 2019;62:3251-3. [DOI: 10.1021/acs.jmedchem.9b00415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Peat AJ, Xie S. Rational Design to Large-Scale Synthesis: Development of GSK8175 for the Treatment of Hepatitis C Virus Infection. ACS Symposium Series 2019. [DOI: 10.1021/bk-2019-1332.ch011] [Reference Citation Analysis]